Azelex Cream
(Azelaic acid)ApprovedSmall molecule
Alnylam PharmaceuticalsAzelaic acid is used to treat two common skin conditions: rosacea (reducing redness, swelling, and bumps on the face) and acne (clearing pimples and reducing swelling). It works by calming skin inflammation and killing bacteria that cause acne.[2] Azelex Cream is currently approved and in use across 4 indications[4].[1]
Azelex Cream is one of 59 small molecule programs targeting Rosacea. It is currently in Approved.
4
Indications
14
Total Trials
2
Active Trials
58
Competitors
3
FDA Applications
NDA/BLA/ANDA regulatory filings
4
Patents
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
2828 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Azelex Cream
Alnylam PharmaceuticalsApproved
Tykerb
GSKPreclinical
Tecentriq
RochePreclinical
Prolia
AmgenPreclinical
Megace
Bristol-Myers SquibbPreclinical
Lexiscan
AstellasPreclinical
Nubain
AAultman Health Foundation
Preclinical
Chirocaine
PPurdue Pharma LP
Preclinical
Ablavar
LLantheus Medical Imaging
Preclinical
Citalopram Hydrobromide
TTorrent Pharmaceuticals Limited
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Rosacea9 trials
Show 6 more trials
Efficacy and Safety2 trials
Breast Cancer1 trial
Regulatory
FDA Approval Timeline[5]
Sep 13, 1995
AZELEX
NDA NDA020428
Dec 24, 2002
FINACEA
NDA NDA021470
Jul 29, 2015
FINACEA
NDA NDA207071
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Azelex Cream drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Azelaic acid. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
- [7]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[3]
- Highest Phase
- Approved[1]
- Company